Replies to post #476 on Idenix Pharmaceuticals (IDIX)

[gofishmarko]

OT : Try saying the title of my last post five times , real fast.

I can't do it , but then again , I only speak well in writing.

[dewophile]

yes - was cited as an advantage for both tyzeka and baraclude, as treatment of one condition should optimally be mutually exclusive of the other as long as cross-resistance is not a concern
anyone have info handy on what percent of the HBV market HIV/HBV coinfection encompasses?
PS: nice to get the EU opinion today - came a bit earlier than I expected